Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:04 PM
Ignite Modification Date:
2025-12-24 @ 7:04 PM
NCT ID:
NCT05912257
Eligibility Criteria:
Inclusion Criteria:
* Male and Female Veterans
* Stage I, II, III cancer of the bladder, colon, kidney, liver, pancreas, stomach or rectum
* Surgery 6 weeks from consent
* Age \> 60 years
* Age-normal renal function
* English speaking
* Able to record dietary intake or has a proxy who can record dietary intake
* Willing and able to be randomized to either intervention group
Exclusion Criteria:
* Stage IV cancer diagnosis
* Glomerular filtration rates (GFR) less than 45 mL/min
* Neurological conditions causing functional impairments, including Parkinson's disease, multiple sclerosis, and permanent disability due to stroke
* Class III-IV congestive heart failure
* Refractory cachexia - medical condition that affects ability to increase muscle mass (e.g., cachexia) defined as 10% weight loss in 10 months, 5% weight loss in 6 months or 2% weight loss over any period plus body mass index 20 kg/m2 AND Life expectancy 9 months
* Active treatment for another cancer site
* Body weight \>450 lbs
* Uncontrolled diabetes (HbA1c 9%)
* Recent diagnosis of thyroid disease or untreated thyroid disease
* Inability to complete physical function assessment
* Severe dietary restrictions
* On chemotherapy drug Sorafenib
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
60 Years
Study:
NCT05912257
Study Brief:
Protocol Section:
NCT05912257